Latest Breaking News On - Pharmetrics plus - Page 2 : comparemela.com

Weight Loss Drug Carries Rare but Severe Stomach Risk, Including Pancreatitis: Study

Weight Loss Drug Carries Rare but Severe Stomach Risk, Including Pancreatitis: Study
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkNovo nordiskJessica folekJournal of the american medical associationAmerican medical associationNorthwell long island jewish forest hillsPatients pastPharmetrics plusObstruction bowelEpoch times

Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss | Clinical Pharmacy and Pharmacology | JAMA

This database study examines the association between glucagon-like peptide 1 agonists (eg, semaglutide, liraglutide) used for weight loss and reports of gastroi

British columbiaUnited kingdomKaren lasserJodyw zylkeMahyar etminanKristin walterUniversity of british columbiaDepartment of ophthalmologyInternational classification of diseasesEye care centerPharmetrics plusInternational classificationNinth revisionDeputy editorVisual sciencesInterest disclosures

GLP-1 weight loss drugs linked to heightened GI risks, says new study

Study from JAMA reveals that users of GLP-1 agonists, recent drugs for weight management, show a heightened risk of gastrointestinal complications like intestinal obstruction, gastroparesis, and pancreatitis. Though these effects are rare, those considering these drugs for weight loss should weigh the benefits against potential risks, especially if not using them for diabetes.

United statesMelnikov dmitriyReceptor agonists for weight loss researchWeight lossImage creditPharmetrics plusGlp 1Glucagon like peptide 1Weight loss

Prior COVID-19 should not impact pharmacological MPI stress testing

Prior COVID‐19 was not associated with a higher risk for complications during and after pharmacologic myocardial perfusion imaging stress testing, data from a large claims database analysis show. “Depending on the local setting, COVID‐19 incidence and availability, the use of pharmacologic myocardial perfusion imaging may be recommended instead of an exercise stress test to

United statesAstellas pharmaDavid walkerPharmetrics plus

Erectile Dysfunction Drugs Linked With Risk for Eye Problems

Popular drugs prescribed for erectile dysfunction may entail an increased risk for adverse eye conditions such as retinal detachment.

United statesUnited kingdomBritish columbiaNawaaz nathooMahyar etminanUniversity of british columbiaMedscape medicalPharmetrics plusErectile dysfunctionEye problemsRetinal detachmentRetinal diseaseDiabetes mellitusOptic neuropathyAnterior ischemic optic neuropathyNterior ischemic optic neuropathy aion